[Multicenter screening of Chlamydia pneumoniae pneumonia by ELISA method]. 1999

T Ishida, and T Hashimoto, and M Arita, and I Ito, and K Ishihara, and M Okazaki, and Y Taguchi
Department of Internal Medicine, Kurashiki Central Hospital.

We prospectively investigated the etiology of community-acquired pneumonia among adult patients admitted to three general hospitals over one year. Antibody titers to Chlamydia pneumoniae were also measured by ELISA method to investigate the incidence and clinical pictures of C. pneumoniae pneumonia in Japan. Two hundred and fourteen patients were enrolled in the study. Seventeen patients (7.9%) satisfied the criteria for diagnosis of acute infection due to C. pneumoniae by ELISA method. C. pneumoniae was the 3rd leading causative agent following Streptococcus pneumoniae (21.5%) and Haemophilus influenzae (8.4%). Preexisting antibodies were detected in 62.1% of the patients. Most of the patients with C. pneumoniae pneumonia were aged, and had comorbidities of respiratory system. Superinfection with bacterial pneumonia was recognized in some patients. Though there are several problems, ELISA method is thought to be useful to diagnose C. pneumoniae pneumonia, and is suitable for screening tests.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002690 Chlamydia Infections Infections with bacteria of the genus CHLAMYDIA. Infections, Chlamydia,Chlamydia Infection,Infection, Chlamydia
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T Ishida, and T Hashimoto, and M Arita, and I Ito, and K Ishihara, and M Okazaki, and Y Taguchi
January 2000, Seminars in respiratory and critical care medicine,
T Ishida, and T Hashimoto, and M Arita, and I Ito, and K Ishihara, and M Okazaki, and Y Taguchi
January 1999, Ryoikibetsu shokogun shirizu,
T Ishida, and T Hashimoto, and M Arita, and I Ito, and K Ishihara, and M Okazaki, and Y Taguchi
September 2000, Praxis,
T Ishida, and T Hashimoto, and M Arita, and I Ito, and K Ishihara, and M Okazaki, and Y Taguchi
January 1998, Revista de medicina de la Universidad de Navarra,
T Ishida, and T Hashimoto, and M Arita, and I Ito, and K Ishihara, and M Okazaki, and Y Taguchi
February 2003, Nihon rinsho. Japanese journal of clinical medicine,
T Ishida, and T Hashimoto, and M Arita, and I Ito, and K Ishihara, and M Okazaki, and Y Taguchi
June 1996, FEMS immunology and medical microbiology,
T Ishida, and T Hashimoto, and M Arita, and I Ito, and K Ishihara, and M Okazaki, and Y Taguchi
November 2002, Internal medicine (Tokyo, Japan),
T Ishida, and T Hashimoto, and M Arita, and I Ito, and K Ishihara, and M Okazaki, and Y Taguchi
May 1999, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
T Ishida, and T Hashimoto, and M Arita, and I Ito, and K Ishihara, and M Okazaki, and Y Taguchi
August 1995, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
T Ishida, and T Hashimoto, and M Arita, and I Ito, and K Ishihara, and M Okazaki, and Y Taguchi
August 1996, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Copied contents to your clipboard!